ABEONA THERAPEUTICS INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Abeona Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2024.
  • Abeona Therapeutics Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $25.4M.
  • Abeona Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $37.1M, a 14.2% decline from 2022.
  • Abeona Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $43.2M, a 73.7% increase from 2021.
  • Abeona Therapeutics Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $24.9M, a 1184% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $25.4M +$25.4M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -$4K* Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2021 $5.88M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2019 $28K -$1.8M -98.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $1.83M +$1.83M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $1K* Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.